Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Repare Therapeutics
Biotech
Repare finds suitor for PKMYT1 inhibitor in partner Debiopharm
Seven months after pressing pause on its plans for its PKMYT1 inhibitor, Repare Therapeutics has found a partner to take the cancer drug forward.
James Waldron
Jul 16, 2025 5:38am
FDA rocked by leadership shake-ups—Chutes & Ladders
Apr 4, 2025 8:30am
Repare unveils scale of layoffs with 75% of staff, CMO departing
Feb 25, 2025 8:05am
Repare cans plans for phase 3 cancer combo trial
Jan 10, 2025 4:30am
Repare lays off 25% of staff as biotech halts preclinical R&D
Aug 29, 2024 6:36am
Canadian VC Amplitude unveils $192M biotech fund
May 29, 2024 10:30am
